Investigation of Digital Media Use in Patients Receiving Chemotherapy (DMU-CH)

April 16, 2026 updated by: Emine I Yıldız, Fenerbahce University

Assessment of Digital Meda Use and eHealth Literacy in Patients Receiving Chemotherapy

This study aims to examine digital media use and eHealth literacy among patients receiving chemotherapy. Digital media has become an important tool for accessing health information, communicating with healthcare providers, and supporting self-management.

This observational study will be conducted with adult patients receiving chemotherapy in an outpatient setting. Data will be collected using a sociodemographic information form and the eHealth Literacy Scale (eHEALS). The findings are expected to contribute to a better understanding of digital media use and digital health literacy levels in chemotherapy patients.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Cancer is a major global health problem, and chemotherapy is one of the most commonly used treatment methods. With the increasing use of digital media, patients frequently access health-related information, communicate with healthcare providers, and engage in self-management. Digital health literacy plays a key role in this process.

This study aims to describe digital media use and eHealth literacy levels among patients receiving chemotherapy. It will also explore the relationship between digital media use and selected patient characteristics.

The study will be conducted as a descriptive, cross-sectional observational study in an outpatient chemotherapy setting. Data will be collected using a sociodemographic information form and the eHealth Literacy Scale (eHEALS).

Study Type

Observational

Enrollment (Estimated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey (Türkiye)
    • Küçükçekmece
      • Istanbul, Küçükçekmece, Turkey (Türkiye)
        • Acıbadem University Atakent Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients aged between 18 and 67 years receiving chemotherapy treatment in an outpatient setting will be included in the study. Participants will be selected according to the inclusion and exclusion criteria and will voluntarily agree to participate.

Description

Inclusion Criteria:

  • Patients aged between 18 and 67 years
  • Receiving chemotherapy treatment
  • Able to communicate and understand the study procedures
  • Voluntarily agree to participate in the study

Exclusion Criteria:

  • Patients with cognitive impairment or communication difficulties
  • Patients who refuse to participate
  • Patients with incomplete questionnaire responses

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Chemotherapy Patients
Patients receiving chemotherapy whose digital media use and eHealth literacy are assessed.
Other: No Intervention (Observational Study)
This is an observational study with no assigned intervention. Data will be collected through surveys assessing digital media use and eHealth literacy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Digital Media Use Level
Time Frame: At baseline (during chemotherapy treatment)
Digital media use will be evaluated based on frequency, duration, and purpose of use through a structured questionnaire.
At baseline (during chemotherapy treatment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
eHealth Literacy Level
Time Frame: At baseline
eHealth literacy will be assessed using the eHealth Literac Scale (eHEALS)
At baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Relationship Between Digital Media Use and eHealth Literacy
Time Frame: At baseline
The association between digital media use and eHealth literacy will be analyzed using statistical methods.
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fenerbahce University

Investigators

  • Principal Investigator: Emine Ilayda Yildiz, Fenerbahce University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 20, 2026

Primary Completion (Estimated)

May 20, 2026

Study Completion (Estimated)

May 20, 2026

Study Registration Dates

First Submitted

March 24, 2026

First Submitted That Met QC Criteria

March 24, 2026

First Posted (Actual)

March 30, 2026

Study Record Updates

Last Update Posted (Actual)

April 21, 2026

Last Update Submitted That Met QC Criteria

April 16, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ASG-YILDIZ-002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe